Abstract:This is a case report of a 29-year-old female patient who developed unilateral mydriasis following the use of a scopolamine patch for the prevention of postoperative nausea and vomiting (PONV).Given a medical history showing multiple risk factors for PONV, a preauricular scopolamine patch was applied prior to the induction of anesthesia. General anesthesia was induced with 150 mg propofol and 25 μg sufentanil and maintained with total intravenous anesthesia, using propofol (5 mg/kg per h) and remifentanil (2-3 μg/kg per h).Following an uneventful surgery of 90min duration, the patient was extubated and transferred to the recovery room, where the patch was removed. During the orthopedic ward round the following day, the clinical examination revealed anisocoria of the left eye in the form of unilateral mydriasis. In order to determine the cause of this clinical presentation, further neurological and ophthalmological examinations and investigations were carried out. In addition, magnetic resonance imaging was conducted to rule out a central nervous cause. The results of the investigations were negative and no pathology was identified. In addition, the symptoms resolved within 24 h of onset without any therapeutic intervention. Therefore, a suspected diagnosis of a pharmacologically induced anisocoria from the scopolamine patch was made, whereby the substance accidentally reached the affected left eye.Previous studies showed that scopolamine patches may reduce early emetic symptoms. Case reports describing the occurrence of anisocoria following the application of scopolamine patches have been previously published. In all of these cases the patches were used to prevent PONV and each case was comprehensively investigated using various diagnostic and clinical tools. It should be noted, however, that a dysfunctional accommodation is listed as a common side effect of the drug, affecting more than 1 in 10 patients.Even though the efficacy of scopolamine patches for the prevention of PONV is proven, clinicians should be aware of the common ophthalmological side effect. Particularly with respect to various surgical disciplines, where anisocoria may indicate an underlying surgery-related complication, the application of scopolamine patches should be well- considered.

Anisocoria in patients with hyperhidrosis: A case series for the primary care physician

Anisocoria secondary to antiperspirant wipes in a pediatric population: a case series

Central Serous Chorioretinopathy Secondary to Drugs: a Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS).

Pharmacologic Mydriasis Secondary to Topical Glycopyrronium Tosylate Cloths: Clinical Characterization From a Multicenter Analysis

Rare Autonomic Nervous System Dysfunction: Alternating Bilateral Mydriasis

Case report of psychosomatic illness: The management of primary hyperhidrosis with oral escitalopram

Primary Hyperhidrosis and Sensitive Skin: Exploring the Link with Predictive Machine Learning-Based Classification Models

[A clinico-pathological case report of necrotizing ulcerating keratopathy due to topical anaesthetic abuse]

[Iatrogenic anisocoria after using a scopolamine patch for PONV prophylaxis]

When to investigate for secondary hyperhidrosis: data from a retrospective cohort of all causes of recurrent sweating

Management of Primary Focal Hyperhidrosis: An Algorithmic Approach

Prevalence and clinical impact of topical corticosteroid phobia among patients with chronic hand eczema - findings from the Danish Skin Cohort

The Prevalence and Severity of Acquired Blepharoptosis in US Eye Care Clinic Patients and Their Receptivity to Treatment

Topical glycopyrrolate for patients with facial hyperhidrosis

Update of the S1 guidelines on the definition and treatment of primary hyperhidrosis

A rare case report: chronic generalized idiopathic pruritus

A systematic evidence-based review of treatments for primary hyperhidrosis

Hyperhidrosis: review of recent advances and new therapeutic options for primary hyperhidrosis

Dry Eye Disease among Patients with Glaucoma under Topical Antiglaucoma Agents in a Tertiary Care Centre: A Descriptive Cross-sectional Study

Mydriasis caused by ESCITALOPRAM: A case report

Sofpironium bromide: an investigational agent for the treatment of axillary hyperhidrosis